Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

China flag China · Delayed Price · Currency is CNY
26.55
-0.48 (-1.78%)
Feb 11, 2026, 4:00 PM EST
Market Cap2.82B +51.2%
Revenue (ttm)196.76M -0.3%
Net Income45.55M -10.5%
EPS0.42 -10.7%
Shares Out108.22M
PE Ratio61.86
Forward PEn/a
Dividend0.32 (1.23%)
Ex-Dividend DateSep 26, 2025
Volume1,707,310
Average Volume1,733,662
Open27.08
Previous Close27.03
Day's Range26.50 - 27.29
52-Week Range14.46 - 28.93
Beta0.54
RSI59.86
Earnings DateApr 25, 2026

About SHA:688163

Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, operation, and sales of antitoxin and antiserum products in China. It offers equine anti-tetanus immunoglobulin, anti-venin, and anti-rabies serum products. The company was founded in 1999 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 324
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688163
Full Company Profile

Financial Performance

In 2024, SHA:688163's revenue was 194.92 million, an increase of 2.51% compared to the previous year's 190.14 million. Earnings were 44.29 million, an increase of 14.23%.

Financial Statements